JSC Chairperson definition

JSC Chairperson has the meaning set forth in Section 3.2.1 (Formation and Purpose of JSC).
JSC Chairperson shall have the meaning ascribed to it in Section 2.7a.1 (JSC Establishment).
JSC Chairperson has the meaning ascribed to such term in Section 5.1.2.

Examples of JSC Chairperson in a sentence

  • A designated representative of Novavax will be the JSC Chairperson until [***], and thereafter the JSC Chairperson will be selected alternately, [***], by SIIPL and then by Novavax.

  • The JSC Chairperson will be responsible for setting the agenda for JSC meetings, with input from the other members, and for conducting the JSC meetings.

  • The JSC Chairperson or his/her delegate shall be responsible for sending invitations and agendas for all JSC meetings to all JSC Members at least [*] before the next scheduled meeting of the JSC.

  • There shall be an annually rotating chairperson of the JSC (“JSC Chairperson”), with the first JSC Chairperson to be designated by [*].

  • The JSC Chairperson shall be responsible for designating a JSC Member, or an attending member of another committee or team, to record in reasonable detail and circulate draft minutes of JSC meetings to all JSC Members for comment and review within [*] after the relevant meeting.


More Definitions of JSC Chairperson

JSC Chairperson has the meaning set forth in Section 4.1.2.
JSC Chairperson shall be a representative of China Company. The JSC Chairperson’s responsibilities shall include (a) scheduling meetings at least [**], but more frequently if the JSC determines it necessary; (b) setting the agenda for meetings with solicited input from other members; (c) confirming and delivering minutes to the JSC for review and final approval; and (d) conducting effective meetings, including ensuring that objectives for each meeting are set and achieved.
JSC Chairperson. 3.1.2 "LEAD VEGF PRODUCT" 2.5 "LEAD ROYALTY-BEARING PRODUCT" 8.3.2.4 "LOSSES" 10.5.1 "MERCK INDEMNITEES" 10.5.1 "NON-ACQUIRED PARTY" 13.2.2 "NON-BANKRUPT PARTY" 12.2.2(c) "NON-BREACHING PARTY" 12.2.1(a) "OPT-OUT PARTY" 4.2 "OPT-OUT PERIOD" AND "OPT-OUT PERIODS" 4.4.1 "OPT-OUT POINT" 4.2 "PARALLEL PROGRAM" 2.14 "PARALLEL PROGRAM INFORMATION" 2.14 "PATENT EXPENSES" 11.3.7 "PHASE I COMPLETION OPT-OUT PERIOD" 4.4.1(b) "PHASE II COMPLETION OPT-OUT PERIOD" 4.4.1(c)
JSC Chairperson shall be a representative of Biogen Idec. The JSC Chairperson's responsibilities shall include (a) scheduling meetings at least once per Contract Quarter, but more frequently if the JSC determines it necessary; (b) setting agendas for meetings with solicited input from other members; (c) confirming and delivering minutes to the JSC for review and final approval; and (d) conducting effective meetings, including ensuring that objectives for each meeting are set and achieved.
JSC Chairperson shall serve for a term of one year, and shall be selected alternately, on an annual basis, by either Party. The JSC Chairperson’s responsibilities shall include: (a) scheduling meetings at least twice per calendar quarter, but more frequently if the JSC determines it necessary; (b) setting agendas for meetings with solicited input from other members; (c) confirming effective meetings, including ensuring that objectives for each meeting are set and achieved and (d) ensuring the preparation of minutes. The JSC Chairperson shall have no additional powers or rights beyond those held by the other JSC representatives.
JSC Chairperson has the meaning set forth in Section 3.2.1 (Formation and Purpose of JSC). 1.105 “Know-How” means algorithms, data, information, inventions, knowledge, methods (including methods of use or administration or dosing), practices, results, software, techniques, technology and trade secrets, including analytical and quality control data, analytical methods (including applicable reference standards), assays, batch records, chemical structures and formulations, compositions of matter, formulae, manufacturing data, pharmacological, toxicological and clinical test data and results, processes, reports, research data, research tools, sequences, standard operating procedures and techniques, in each case, whether patentable or not, and, in each case, tangible manifestations thereof. 1.106 “Knowledge” means, with respect to a Party, the actual knowledge of those Persons listed for such Party on Schedule 1.106 (Knowledge) after due inquiry of such Person’s direct reports. 1.107 “Launch Quarter” has the meaning set forth in Section 10.3.3(b) (Generic Competition). 1.108 “Licensed Know-How” means any Know-How that is (a)
JSC Chairperson. 4.1.2 "LOSSES" 10.5.1 "MERCK-ASSIGNED THERAPEUTIC COLLABORATION INVENTIONS" 11.2(d) "MERCK DEVELOPMENT PRODUCT" 3.2.2(d) "MERCK DEVELOPMENT TARGET" 3.2.2(d) "MERCK INDEMNITEES" 10.5.2 "MERCK RNAI NOVEL TARGET INFORMATION" 3.2.2(b) "MERCK TECHNOLOGY" 7.1.3(a) "NON-ACQUIRED PARTY" 13.3.1 "NON-BANKRUPT PARTY" 12.3.5 "NON-BREACHING PARTY" 12.2.1(a) "NOVARTIS" Schedule 1.83 "NOVARTIS AGREEMENT" Schedule 1.83 "OPT-IN INFORMATION" 2.2.2(a) "OPT-IN NOTICE" 2.2.2(b) "OPT-IN PERIOD" 2.2.2(a) "OPT-IN RIGHT" 2.2.2(a) "OPT-OUT NOTICE" 5.1(a) "OPT-OUT PARTY" 5.1(a) "OPT-OUT POINT" 5.1(b) "OPT-OUT RIGHT" 5.1 "ORIGINAL AGREEMENT" Recitals "ORIGINAL EFFECTIVE DATE" Recitals "PATENT EXPENSES" 11.3.7 "PROFIT-SHARING PRODUCT" 3.2.2(c) "PROGRAM" 3.3 "PROGRAM WORKPLAN" 3.3 "PROSECUTING PARTY" 11.3.5 "PROVIDERS" 10.1(e) "RECEIVING PARTY" 12.4.1 "REGION" 12.3.6 "REQUESTED PARTY" 3.7 "[**]" 2.2.1 "ROYALTY-BEARING PRODUCT" 5.1 "SECONDARY ENFORCEMENT RIGHTS PARTY" 11.5.3 "SELECTION NOTICE" 3.2.2(c) "SIGNIFICANT PHARMACEUTICAL COMPANY" 13.3.3